Patterns of practice and pharmacoeconomic analysis of the management of patients with metastatic renal cell carcinoma (mRCC) in Greece––the CRISIS study. A retrospective analysis by the Hellenic Genitourinary Cancer Group (HGUCG)-Reference-Cited by-同舟云学术

Patterns of practice and pharmacoeconomic analysis of the management of patients with metastatic renal cell carcinoma (mRCC) in Greece––the CRISIS study. A retrospective analysis by the Hellenic Genitourinary Cancer Group (HGUCG)

Published:2018-11-19 Issue:4 Volume:19 Page:491-501
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Tsironis Georgiops¹²,Koutsoukos Konstantinos¹²,Athanasakis Konstantinos³,Tsiara Anna¹,Tzannis Kimon²,Gerolympou Margarita⁴,Visvikis Anastasios⁴,Oikonomopoulos Georgios⁵,Kollia Alexandra²,Giannopoulou Efstathia²,Dimitra Marialena²,Kostouros Efthymios¹,Papatsoris Athanasios²⁶,Dellis Athanasios²⁷,Stravodimos Konstantinos²⁸,Varkarakis Ioannis²⁶,Samantas Epaminontas⁴,Aravantinos Gerasimos.⁹,Kentepozidis Nikolaos¹⁰,Christodoulou Christos⁵,Bozionelou Vasiliki¹¹,Dimopoulos Meletios Athanasios.¹²,Bamias Aristotle¹²

Affiliation:

1. Oncology Unit, Department of Clinical Therapeutics, Alexandra Hospital, University of Athens, Athens, Greece

2. Hellenic Genito-Urinary Cancer Group, Athens, Greece

3. Department of Health Economics, National School of Public Health, Athens, Greece

4. 3rd Oncology Clinic, General Oncology Hospital of Kifisias “Ag. Anargyroi”, Athens, Greece

5. 2nd Oncology Clinic, Metropolitan Hospital, Piraeus, Greece

6. 2nd Department of Urology, Sismanoglio General Hospital, University of Athens, Athens, Greece

7. 2nd Department of Surgery, Aretaieion Academic Hospital, University of Athens, Athens, Greece

8. 1st University Urology Clinic, Laiko Hospital, University of Athens, Athens, Greece

9. 2nd Oncology Clinic, General Oncology Hospital of Kifisias “Ag. Anargyroi”, Athens, Greece

10. Department of Medical Oncology, 251 Airforce General Hospital, Athens, Greece

11. Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Greece

Funder

Hellenic GU Cancer Group (HGUCG)

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2019.1546121

Reference40 articles.

1. Howlader N, Noone AM, Krapcho M, et al. SEER cancer statistics review, 1975–2014, National Cancer Institute April 2017; based on November 2016 SEER data submission]. [cited 2018 Jul]. Available from: https://seer.cancer.gov/csr/1975_2014/

2. Ferlay J, Shin HR, Bray F, et al. GLOBOCAN 2008 v1.2, cancer incidence and mortality worldwide: IARC cancerbase no. 10 [intern.lyon, France: International Agency for Research on Cancer 2010 [cited2013 Jun]. Available from: http://globocan.iarc.fr/

3. Ljungberg B, Albiges L, Bensalah K, et al. Guidelines on renal cell carcinoma. European Association of Urology [cited 2018 Jul]. Available from: http://uroweb.org/guideline/renal-cell-carcinoma/#1

4. Interferon-Alfa as a Comparative Treatment for Clinical Trials of New Therapies Against Advanced Renal Cell Carcinoma

5. Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes from treatment of metastatic renal-cell carcinoma following failure of first-line anti-VEGF/VEGFR therapy: real-life evidence on the change of the treatment paradigm;Anti-Cancer Drugs;2022-11-16